HALOZYME THERAPEUTICS, INC. Earnings Per Share Diluted

Quick Answer

HALOZYME THERAPEUTICS, INC. reported Earnings Per Share Diluted of $2.56 per share for the year ending 2025.

  • HALOZYME THERAPEUTICS, INC. showed a decrease of -25.4% in Earnings Per Share Diluted from 2024 to 2025.
  • This data is from HALOZYME THERAPEUTICS, INC.'s annual report (Form 10-K), filed with the SEC on February 17, 2026.
  • XBRL data for this metric is available from 2015 to 2025 (11 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 11 years of available data (2015 to 2025), HALOZYME THERAPEUTICS, INC.'s Earnings Per Share Diluted has grown by 1,124.0%.
  • Historical annual values: Fiscal year 2025: $2.56 per share | Fiscal year 2024: $3.43 per share | Fiscal year 2023: $2.10 per share | Fiscal year 2022: $1.44 per share | Fiscal year 2021: $2.74 per share | Fiscal year 2020: $0.91 per share | Fiscal year 2019: $0.50 (loss) per share | Fiscal year 2018: $0.56 (loss) per share | Fiscal year 2017: $0.45 per share | Fiscal year 2016: $0.81 (loss) per share | Fiscal year 2015: $0.25 (loss) per share.
  • Data sourced from SEC EDGAR public filings as of June 22, 2026.

Last verified: